Director/PDMR Shareholding

Summary by AI BETAClose X

TP ICAP Group plc announced the vesting of awards under its Deferred Bonus Share Plan and Restricted Share Plan on March 31, 2026, resulting in the release of 1,910,861 ordinary shares. Persons discharging managerial responsibilities (PDMRs) sold a portion of these shares at £2.7075 each to cover tax liabilities and dealing charges, retaining the remainder. Nicolas Breteau, Chief Executive Officer, retained 288,696 shares from the 2023 RSP award, Robin Stewart, Chief Financial Officer, retained 171,011 shares, and Philip Price, Group General Counsel, retained 174,688 shares from the same award, with similar retention patterns across other vested awards.

Disclaimer*

TP ICAP Group plc
02 April 2026
 

TP ICAP Group plc

LEI: 2138006YAA7IRVKKGE63

2 April 2026

TP ICAP Group plc (the 'Company' or 'TP ICAP')

Notification of transactions by persons discharging managerial responsibilities ('PDMRs')

On 1 April 2026, the Company received notifications relating to:

·     the vesting of tranche 3 of the awards granted on 31 March 2023 over ordinary shares of 25p each in the Company (the 'Company Shares') under the TP ICAP Group plc Deferred Bonus Share Plan (the '2023 DBSP');

·     the vesting of tranche 2 of the awards granted on 31 March 2024 over the Company Shares under the TP ICAP Group plc Deferred Bonus Share and Cash Plan (the '2024 DBSP');

·     the vesting of tranche 1 of the awards granted on 28 March 2025 over the Company Shares under the TP ICAP Group plc Deferred Bonus Share and Cash Plan (the '2025 DBSP'); and

·     the vesting of awards granted on 31 March 2023 over the Company Shares under the TP ICAP Group plc Restricted Share Plan (the '2023 RSP').

Vesting of awards

Following the vestings on 31 March 2026, a total of 1,910,861 Company Shares were released by the TP ICAP Employee Benefit Trust (the 'EBT') to the PDMRs named in the table below. Each PDMR elected to sell a number of shares to settle the income tax and national insurance ('NI') liabilities and dealing charges arising on vesting. These market sales were completed on 31 March 2026. For awards vesting under the 2023 DBSP, the 2024 DBSP and the 2025 DBSP, a further six-month post-vesting retention period applies. For awards vesting under the 2023 RSP, a further two-year post-vesting holding period applies.

The table below sets out the number of Company Shares released to each PDMR, the number subsequently sold to discharge income tax, NI and dealing charges arising on vesting, and the number retained by each PDMR.

PDMR

Nicolas Breteau

Robin Stewart

Philip Price

Title

Chief Executive Officer

Chief Financial Officer

Group General Counsel

2023 DBSP

Company Shares released

 

108,112

49,966

51,820

Company Shares sold to discharge income tax, NI and dealing charges

51,017

23,579

24,454

Sale price per Company Share (£)

 

2.7075

2.7075

2.7075

Company Shares retained

 

57,095

26,387

27,366

2024 DBSP

Company Shares released

 

138,263

65,178

65,528

Company Shares sold to discharge income tax, NI and dealing charges

65,245

30,757

30,922

Sale price per Company Share (£)

 

2.7075

2.7075

2.7075

Company Shares retained

 

73,018

34,421

34,606

2025 DBSP

Company Shares released

 

118,632

56,057

56,053

Company Shares sold to discharge income tax, NI and dealing charges

55,981

26,452

26,450

Sale price per Company Share (£)

 

2.7075

2.7075

2.7075

Company Shares retained

 

62,651

29,605

29,603

2023 RSP

Company Shares released

 

546,657

323,816

330,779

Company Shares sold to discharge income tax, NI and dealing charges

257,961

152,805

156,091

Sale price per Company Share (£)

 

2.7075

2.7075

2.7075

Company Shares retained

 

288,696

171,011

174,688

 

Notifications

The following notifications are made in accordance with the requirements of the UK Market Abuse Regulation and provide further detail.

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Nicolas Breteau

 

2

Reason for the notification

 

a)

Position/status

Director and PDMR

 

b)

Initial notification / amendment

Initial notification

 

3

Details of the issuer

 

a)

Name

TP ICAP Group plc

 

b)

LEI

2138006YAA7IRVKKGE63

 

4

Details of the transaction(s)

 

2023 DBSP

a)

Description of the financial instrument, type of instrument / Identification code

Ordinary shares of 25p each / JE00BMDZN391

b)

Nature of the transaction

(1)   Transfer of Company Shares from the EBT to the PDMR following the vesting of tranche 3 of the 2023 DBSP award.

(2)   Sale of Company Shares to meet the income tax and national insurance liabilities and dealing charges arising upon the vesting of tranche 3 of the 2023 DBSP award.

c)

Price(s) and volume(s)

 


Price(s)

Volume(s)

(1)

£Nil

108,112

(2)

£2.7075

51,017

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

(1) 108,112

(2) 51,017

 

(1) £Nil

(2) £2.7075

 

e)

Date of the transaction

 

31 March 2026

f)

Place of the transaction

 

(1)   Outside a trading venue

(2)   London Stock Exchange

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

2024 DBSP

a)

Description of the financial instrument, type of instrument / Identification code

Ordinary shares of 25p each / JE00BMDZN391

b)

Nature of the transaction

(1)   Transfer of Company Shares from the EBT to the PDMR following the vesting of tranche 2 of the 2024 DBSP award.

(2)   Sale of Company Shares to meet the income tax and national insurance liabilities and dealing charges arising upon the vesting of tranche 2 of the 2024 DBSP award.

 

c)

Price(s) and volume(s)

 


Price(s)

Volume(s)

(1)

£Nil

138,263

(2)

£2.7075

65,245

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

(1) 138,263

(2) 65,245

 

(1) £Nil

(2) £2.7075

 

e)

Date of the transaction

 

31 March 2026

f)

Place of the transaction

 

(1)   Outside a trading venue

(2)   London Stock Exchange

 

 

2025 DBSP

a)

Description of the financial instrument, type of instrument / Identification code

Ordinary shares of 25p each / JE00BMDZN391

b)

Nature of the transaction

(1)   Transfer of Company Shares from the EBT to the PDMR following the vesting of tranche 1 of the 2025 DBSP award.

(2)   Sale of Company Shares to meet the income tax and national insurance liabilities and dealing charges arising upon the vesting of tranche 1 of the 2025 DBSP award.

 

c)

Price(s) and volume(s)

 

 

 

 

 

 


Price(s)

Volume(s)

(1)

£Nil

118,632

(2)

£2.7075

55,981

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

(1) 118,632

(2) 55,981

 

(1) £Nil

(2) £2.7075

 

e)

Date of the transaction

 

31 March 2026

f)

Place of the transaction

 

(1)   Outside a trading venue

(2)   London Stock Exchange

 

4

Details of the transaction(s)

 

2023 RSP

a)

Description of the financial instrument, type of instrument / Identification code

Ordinary shares of 25p each / JE00BMDZN391

b)

Nature of the transaction

(1)   Transfer of Company Shares from the EBT to the PDMR following the vesting of the 2023 RSP award.

(2)   Sale of Company Shares to meet the income tax and national insurance liabilities and dealing charges arising upon the vesting of the RSP 2023 award.

 

c)

Price(s) and volume(s)

 


Price(s)

Volume(s)

(1)

£Nil

546,657

(2)

£2.7075

257,961

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

(1) 546,657

(2) 257,961

 

(1) £Nil

(2) £2.7075

 

e)

Date of the transaction

 

31 March 2026

f)

Place of the transaction

 

(1)   Outside a trading venue

(2)   London Stock Exchange

 

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Robin Stewart

 

2

Reason for the notification

 

a)

Position/status

Director and PDMR

 

b)

Initial notification / amendment

Initial notification

 

3

Details of the issuer

 

a)

Name

TP ICAP Group plc

 

b)

LEI

2138006YAA7IRVKKGE63

 

4

Details of the transaction(s)

 

2023 DBSP

a)

Description of the financial instrument, type of instrument / Identification code

Ordinary shares of 25p each / JE00BMDZN391

b)

Nature of the transaction

(1)   Transfer of Company Shares from the EBT to the PDMR following the vesting of tranche 3 of the 2023 DBSP award.

(2)   Sale of Company Shares to meet the income tax and national insurance liabilities and dealing charges arising upon the vesting of tranche 3 of the 2023 DBSP award.

 

c)

Price(s) and volume(s)

 


Price(s)

Volume(s)

(1)

£Nil

49,966

(2)

£2.7075

23,579

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

(1) 49,966

(2) 23,579

 

(1) £Nil

(2) £2.7075

 

e)

Date of the transaction

 

31 March 2026

f)

Place of the transaction

 

(1)   Outside a trading venue

(2)   London Stock Exchange

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

2024 DBSP

a)

Description of the financial instrument, type of instrument / Identification code

Ordinary shares of 25p each / JE00BMDZN391

b)

Nature of the transaction

(1)   Transfer of Company Shares from the EBT to the PDMR following the vesting of tranche 2 of the 2024 DBSP award.

(2)   Sale of Company Shares to meet the income tax and national insurance liabilities and dealing charges arising upon the vesting of tranche 2 of the 2024 DBSP award.

 

c)

Price(s) and volume(s)

 


Price(s)

Volume(s)

(1)

£Nil

65,178

(2)

£2.7075

30,757

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

(1) 65,178

(2) 30,757

 

(1) £Nil

(2) £2.7075

 

e)

Date of the transaction

 

31 March 2026

f)

Place of the transaction

 

(1)   Outside a trading venue

(2)   London Stock Exchange

 

 

2025 DBSP

a)

Description of the financial instrument, type of instrument / Identification code

Ordinary shares of 25p each / JE00BMDZN391

b)

Nature of the transaction

(1)   Transfer of Company Shares from the EBT to the PDMR following the vesting of tranche 1 of the 2025 DBSP award.

(2)   Sale of Company Shares to meet the income tax and national insurance liabilities and dealing charges arising upon the vesting of tranche 1 of the 2025 DBSP award.

 

c)

Price(s) and volume(s)

 


Price(s)

Volume(s)

(1)

£Nil

56,057

(2)

£2.7075

26,452

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

(1) 56,057

(2) 26,452

 

(1) £Nil

(2) £2.7075

 

e)

Date of the transaction

 

31 March 2026

f)

Place of the transaction

 

(1)   Outside a trading venue

(2)   London Stock Exchange

 

4

Details of the transaction(s)

 

2023 RSP

a)

Description of the financial instrument, type of instrument / Identification code

Ordinary shares of 25p each / JE00BMDZN391

b)

Nature of the transaction

(1)   Transfer of Company Shares from the EBT to the PDMR following the vesting of the TP ICAP Group plc RSP 2023 award.

(2)   Sale of Company Shares to meet the income tax and national insurance liabilities and dealing charges arising upon the vesting of the RSP 2023 award.

 

c)

Price(s) and volume(s)

 


Price(s)

Volume(s)

(1)

£Nil

323,816

(2)

£2.7075

152,805

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

(1) 323,816

(2) 152,805

 

(1) £Nil

(2) £2.7075

 

e)

Date of the transaction

 

31 March 2026

f)

Place of the transaction

 

(1)   Outside a trading venue

(2)   London Stock Exchange

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

 

a)

Name

Philip Price

 

2

Reason for the notification

 

a)

Position/status

Director and PDMR

 

b)

Initial notification / amendment

Initial notification

 

3

Details of the issuer

 

a)

Name

TP ICAP Group plc

 

b)

LEI

2138006YAA7IRVKKGE63

 

4

Details of the transaction(s)

 

2023 DBSP

a)

Description of the financial instrument, type of instrument / Identification code

Ordinary shares of 25p each / JE00BMDZN391

b)

Nature of the transaction

(1)   Transfer of Company Shares from the EBT to the PDMR following the vesting of tranche 3 of the 2023 DBSP award.

(2)   Sale of Company Shares to meet the income tax and national insurance liabilities and dealing charges arising upon the vesting of tranche 3 of the 2023 DBSP award.

 

c)

Price(s) and volume(s)

 


Price(s)

Volume(s)

(1)

£Nil

51,820

(2)

£2.7075

24,454

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

(1) 51,820

(2) 24,454

 

(1) £Nil

(2) £2.7075

 

e)

Date of the transaction

 

31 March 2026

f)

Place of the transaction

 

(1)   Outside a trading venue

(2)   London Stock Exchange

 

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

2024 DBSP

a)

Description of the financial instrument, type of instrument / Identification code

Ordinary shares of 25p each / JE00BMDZN391

b)

Nature of the transaction

(1)   Transfer of Company Shares from the EBT to the PDMR following the vesting of tranche 2 of the 2024 DBSP award.

(2)   Sale of Company Shares to meet the income tax and national insurance liabilities and dealing charges arising upon the vesting of tranche 2 of the 2024 DBSP award.

 

c)

Price(s) and volume(s)

 


Price(s)

Volume(s)

(1)

£Nil

65,528

(2)

£2.7075

30,922

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

(1) 65,528

(2) 30,922

 

(1) £Nil

(2) £2.7075

 

e)

Date of the transaction

 

31 March 2026

f)

Place of the transaction

 

(1)   Outside a trading venue

(2)   London Stock Exchange

 

 

2025 DBSP

a)

Description of the financial instrument, type of instrument / Identification code

Ordinary shares of 25p each / JE00BMDZN391

b)

Nature of the transaction

(1)   Transfer of Company Shares from the EBT to the PDMR following the vesting of tranche 1 of the 2025 DBSP award.

(2)   Sale of Company Shares to meet the income tax and national insurance liabilities and dealing charges arising upon the vesting of tranche 1 of the 2025 DBSP award.

 

c)

Price(s) and volume(s)

 


Price(s)

Volume(s)

(1)

£Nil

56,053

(2)

£2.7075

26,450

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

(1) 56,053

(2) 26,450

 

(1) £Nil

(2) £2.7075

 

e)

Date of the transaction

 

31 March 2026

f)

Place of the transaction

 

(1)   Outside a trading venue

(2)   London Stock Exchange

 

4

Details of the transaction(s)

 

2023 RSP

a)

Description of the financial instrument, type of instrument / Identification code

Ordinary shares of 25p each / JE00BMDZN391

b)

Nature of the transaction

(1)   Transfer of Company Shares from the EBT to the PDMR following the vesting of the TP ICAP Group plc RSP 2023 award.

(2)   Sale of Company Shares to meet the income tax and national insurance liabilities and dealing charges arising upon the vesting of the RSP 2023 award.

 

c)

Price(s) and volume(s)

 


Price(s)

Volume(s)

(1)

£Nil

330,779

(2)

£2.7075

156,091

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

(1) 330,779

(2) 156,091

 

(1) £Nil

(2) £2.7075

 

e)

Date of the transaction

 

31 March 2026

f)

Place of the transaction

 

(1)   Outside a trading venue

(2)   London Stock Exchange

 

 

 

Enquiries

Victoria Hames

Interim Group Company Secretary

 

Ceri Young

Deputy Company Secretary

 

+44 (0)20 3933 0448

companysecretarial@tpicap.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings